Trexquant Investment LP Cuts Position in Nu Skin Enterprises, Inc. $NUS

Key Points

• Trexquant Investment LP has reduced its stake in Nu Skin Enterprises by 45.5%, bringing its total shares owned to 312,794, valued at approximately $2.27 million.
• Insider trading activity includes a sale of 6,489 shares by Director Laura Nathanson and 20,000 shares by EVP Chayce David Clark, reflecting a general trend of insider selling in the company.
• Financial analysts have upgraded Nu Skin's rating, with a consensus rating of "Hold" and a target price of $6.88, after the company reported better-than-expected earnings results.

Trexquant Investment LP lowered its position in shares of Nu Skin Enterprises, Inc. (NYSE:NUS - Free Report) by 45.5% during the first quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 312,794 shares of the company's stock after selling 261,123 shares during the period. Trexquant Investment LP owned approximately 0.63% of Nu Skin Enterprises worth $2,271,000 as of its most recent SEC filing.

A number of other hedge funds also recently made changes to their positions in the company. Ieq Capital LLC purchased a new stake in shares of Nu Skin Enterprises during the first quarter valued at approximately $279,000. Walleye Capital LLC raised its stake in shares of Nu Skin Enterprises by 31.2% during the first quarter. Walleye Capital LLC now owns 334,913 shares of the company's stock valued at $2,431,000 after purchasing an additional 79,577 shares during the period. Martingale Asset Management L P raised its stake in shares of Nu Skin Enterprises by 10.9% during the first quarter. Martingale Asset Management L P now owns 106,187 shares of the company's stock valued at $771,000 after purchasing an additional 10,443 shares during the period. Hsbc Holdings PLC purchased a new stake in shares of Nu Skin Enterprises during the first quarter valued at approximately $619,000. Finally, Versor Investments LP raised its stake in shares of Nu Skin Enterprises by 251.6% during the first quarter. Versor Investments LP now owns 41,085 shares of the company's stock valued at $298,000 after purchasing an additional 29,400 shares during the period. Hedge funds and other institutional investors own 82.84% of the company's stock.

Insiders Place Their Bets

In other Nu Skin Enterprises news, Director Laura Nathanson sold 6,489 shares of Nu Skin Enterprises stock in a transaction on Thursday, September 4th. The shares were sold at an average price of $12.22, for a total value of $79,295.58. Following the completion of the transaction, the director owned 33,149 shares of the company's stock, valued at $405,080.78. The trade was a 16.37% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available through this link. Also, EVP Chayce David Clark sold 20,000 shares of the business's stock in a transaction on Wednesday, September 3rd. The shares were sold at an average price of $11.97, for a total transaction of $239,400.00. Following the transaction, the executive vice president directly owned 233,140 shares of the company's stock, valued at approximately $2,790,685.80. This trade represents a 7.90% decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 58,926 shares of company stock valued at $711,364 over the last 90 days. 2.00% of the stock is owned by company insiders.

Wall Street Analysts Forecast Growth

A number of analysts have recently issued reports on the stock. Zacks Research upgraded shares of Nu Skin Enterprises to a "hold" rating in a research note on Tuesday, August 12th. Wall Street Zen raised shares of Nu Skin Enterprises from a "buy" rating to a "strong-buy" rating in a research report on Friday, August 22nd. Three investment analysts have rated the stock with a Hold rating, According to data from MarketBeat, the company has a consensus rating of "Hold" and a consensus target price of $6.88.

Nu Skin Enterprises Stock Performance

Nu Skin Enterprises stock opened at $12.29 on Friday. The company has a market cap of $608.11 million, a PE ratio of 6.11 and a beta of 0.92. The company has a fifty day moving average price of $9.88 and a two-hundred day moving average price of $8.13. The company has a debt-to-equity ratio of 0.27, a current ratio of 2.01 and a quick ratio of 1.38. Nu Skin Enterprises, Inc. has a 12 month low of $5.32 and a 12 month high of $12.40.

Nu Skin Enterprises (NYSE:NUS - Get Free Report) last released its quarterly earnings data on Thursday, August 7th. The company reported $0.43 EPS for the quarter, topping analysts' consensus estimates of $0.25 by $0.18. The firm had revenue of $386.14 million during the quarter, compared to the consensus estimate of $376.68 million. Nu Skin Enterprises had a net margin of 6.20% and a return on equity of 8.23%. Nu Skin Enterprises has set its FY 2025 guidance at 1.150-1.350 EPS. Research analysts expect that Nu Skin Enterprises, Inc. will post 1.05 earnings per share for the current year.

Nu Skin Enterprises Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Wednesday, September 10th. Shareholders of record on Friday, August 29th will be issued a $0.06 dividend. This represents a $0.24 dividend on an annualized basis and a yield of 2.0%. The ex-dividend date of this dividend is Friday, August 29th. Nu Skin Enterprises's payout ratio is currently 11.94%.

Nu Skin Enterprises Company Profile

Nu Skin Enterprises, Inc, together with its subsidiaries, engages in the development and distribution of various beauty and wellness products worldwide. It offers skin care devices, cosmetics, and other personal care products, including ageLOC LumiSpa and ageLOC LumiSpa iO; and nutricentials skin care products.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.